Table 1.
Baseline characteristics.
| N = 40 | |
|---|---|
| Age | |
| Mean ± sd | 53 ± 14.4 |
| Gender | |
| Female | 26 (65%) |
| Race | |
| White, n (%) | 13 (32.5%) |
| Asian, n (%) | 3 (7.5%) |
| African American, n (%) | 1 (2.5%) |
| Missing, n (%) | 23 (57.5%) |
| Select Medical History | |
| OSA | 14 (35%) |
| Depression | 13 (32.5%) |
| RLS | 10 (25%) |
| Concomitant Psychiatric Medication Use | |
| SSRI | 15 (37.5%) |
| Benzodiazepine | 8 (20%) |
| Other Medications | |
| Dopamine agonist | 5 (12.5%) |
| Zolpidem Total Daily Dosagea | |
| 5 mg | 1 (2.5%) |
| 6.25 mg | 1 (2.5%) |
| 10 mg | 30 (75%) |
| 12.5 mg | 4 (10%) |
| 15 mg | 1 (2.5%) |
| 20 mg | 2 (5%) |
| 30 mg | 1 (2.5%) |
| SRED Frequency | |
| Nightly | 23 (57.5%) |
| Weekly | 5 (12.5%) |
| Monthly | 3 (7.5%) |
| Yearly | 4 (10%) |
| Unknown | 5 (12.5%) |
| Amnesia of episodes | |
| Total | 22 (55%) |
| Partial | 8 (20%) |
| Unknown Level of Amnesia | 10 (25%) |
OSA = obstructive sleep apnea.
RLS = restless leg syndrome.
SSRI = selective serotonin receptor inhibitor.
a
If the patient was prescribed a range, we report the maximum dosage allowed.